Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company has reached a major milestone for long-term stability testing on its flagship THC-free cannabidiol (CBD) oil product Real Scientific Hemp Oil-X™ (RSHO-XTM). The stability study was conducted in strict compliance with FDA/ICH guidelines (Q1A-R2).   ” data-reactid=”11″>SAN DIEGO, June 12,  2019 /PRNewswire/ — Medical Marijuana, Inc. (MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company has reached a major milestone for long-term stability testing on its flagship THC-free cannabidiol (CBD) oil product Real Scientific Hemp Oil-X™ (RSHO-XTM). The stability study was conducted in strict compliance with FDA/ICH guidelines (Q1A-R2).   

Stability Study Results RSHO-X

Stuart Titus. “Our company set the standards for many CBD testing protocols in the U.S. and intends to continue doing so with this study. Our customers strongly rely on the quality, potency and safety of RSHO-X, which has been tested in two successful pilot clinical studies. Therefore, we take it seriously to keep the quality standard criteria higher for our products and provide accurate and specific safety and expiration information.”

“The results from the study provide significant evidence that RSHO-X has a shelf-life of at least 12 months at different and extreme climate conditions. This helps the company ensure to its customers and retailers that the integrity of the product will not be compromised while in transportation or while being stored for future use,” said Medical Marijuana, Inc. Vice President of Project Analysis and R&D, Dr. Levan Darjania. “The purpose of this accelerated and long-term testing was to evaluate the stability profile of RSHO-X and to assess the product’s performance and safety as well as the acceptability according to the FDA-ICH Guideline on stability testing.”

The data obtained from this study also reveals indications about the behavior of RSHO-X™ over determined time intervals while facing the different environmental conditions to which it may be exposed from the production date until the end of its validity. The study was outsourced to one of the most qualified cGLP/cGMP compliant Contract Research Organizations (CROs) with attained ISO 17025 accreditation and certification.

Europe, Mexico and Brazil. CBD quantitation tests were performed using fully validated, proprietary analytical UPLC-PDA and LC-MS/MS methods reflecting the specificity and selectivity toward RSHO-X™, including data elements and parameters such as accuracy, precision, repeatability, ruggedness, system suitability, linearity, specificity, dilution integrity and dynamic range. In addition to CBD monitoring and quantitation, the stability samples were tested for appearance, odor, specific gravity, viscosity, package compatibility and complete microbial test characteristics.

The test results showed that no change (more than 5%) in the CBD content and other specifications were observed and the container closure system was faultless at both long-term and accelerated test conditions.

The positive 6-month accelerated and 9-month long-term stability test results suggest that RSHO-X™ is a stable formulation. A preliminary shelf-life of 12 months was derived from the primary and supportive data. The stability testing will be continued up to 24 months. A corresponding shelf-life of 24 months is anticipated.

www.medicalmarijuanainc.com.” data-reactid=”33″>To learn more about the study or Medical Marijuana, Inc., please visit: www.medicalmarijuanainc.com.

We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its internal R&D and scientific team and its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com.” data-reactid=”34″>About Medical Marijuana, Inc.
We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its internal R&D and scientific team and its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com.

click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.” data-reactid=”35″>To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.

andrew.hard@cmwmedia.com
www.cmwmedia.com” data-reactid=”39″>CONTACT:
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 858-264-6600
andrew.hard@cmwmedia.com
www.cmwmedia.com

Investors@medicalmarijuanainc.com” data-reactid=”40″>Investor Relations Contact:
P. (858) 283-4016
Investors@medicalmarijuanainc.com

 

Cision

http://www.prnewswire.com/news-releases/medical-marijuana-inc-announces-completion-of-the-first-ever-high-level-stability-study-on-a-cbd-hemp-oil-product-300866129.html” data-reactid=”53″>View original content to download multimedia:http://www.prnewswire.com/news-releases/medical-marijuana-inc-announces-completion-of-the-first-ever-high-level-stability-study-on-a-cbd-hemp-oil-product-300866129.html